
Smartphones Are Helping Health Workers Combat Tuberculosis
Encrypted videos enable medication monitoring from afar
STAT delivers fast, deep, and tough-minded journalism. We take you inside science labs and hospitals, biotech boardrooms, and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all.

Smartphones Are Helping Health Workers Combat Tuberculosis
Encrypted videos enable medication monitoring from afar

N.Y.U. Medical School Students Will Get Free Tuition
The move could have benefits far beyond one medical school

Doctors Prescribe Fewer Opioids after Learning of Patient Deaths
Clinicians were contacted about fatal overdoses

Inducing Labor at 39 Weeks Safe, Linked to Lower C-Section Risk
The big study finding upends conventional thinking

1 in 7 Babies Exposed to Zika in the Womb Have Health Problems
Some of the children looked healthy at birth

New Ebola Outbreak Declared in the Democratic Republic of the Congo
Experimental therapies, shipped to the DRC for its last outbreak, are still in the country

Alzheimer's Study Sparks a New Round of Debate over the Amyloid Hypothesis
Does the data in a recent clinical trial support the idea that removing amyloid clumps can improve mental functioning?

Experimental Alzheimer’s Drug Significantly Slowed Patients’ Cognitive Decline
The surprising results have buoyed hopes for treatment

Will Trump’s Plans Bring Down Drug Prices?
Healthcare experts seek to unpack the bold and the bluster in the varying proposals

FDA Chief Slams Drugmakers for Stalling Release of Biosimilars
Americans could have saved $4.5 billion last year if these products were more available, agency official says

Resistance to Gonorrhea Spurs Bespoke Treatments
Researchers are developing diagnostics to determine which drugs might work for specific patients

Potential DNA Damage from CRISPR “Seriously Underestimated,” Study Finds
A flurry of recent findings highlight a contentious question in this area

CRISPR Makes Cancer Cells Turncoats That Attack Their Tumor
The experimental approach showed promise across three types of malignancies in mice

A Flu Drug May Be Poised to Upend Treatment in U.S.
The medication can reduce the duration of symptoms

Psychiatrists Call for Rollback of Policy Banning Discussion of Public Figures’ Mental Health
Famed Goldwater Rule adopted by the American Psychiatric Association is said to deprive the public of expert analysis about the mental health of elected leaders

Poliovirus Therapy Shows Early Promise for Treating Aggressive Brain Cancer, but Questions Linger
Survival was better than expected with this genetically modified pathogen

FDA Approves Country’s First Marijuana-Based Medicine
The drug will treat two rare forms of epilepsy

Will Launching Plants into Orbit Yield New Medicines?
Many Earth-bound efforts focus on synthetic chemicals, but some researchers hope the stress of space could provide new insights

What’s in the House Bills to Address the Opioid Crisis—and What’s Not
Lawmakers are considering 57 separate pieces of legislation

Facebook Redirects Users Searching for Opioids to Federal Crisis Help Line
Tech giants are grappling with questions about illicit sales on their platforms

7 Questions to Watch in the Theranos Saga
Since criminal charges were filed, these may be the most pressing issues

Dengue Vaccine Maker Struggles to Find a Diagnostic That Will Make Its Product Safe to Use
Right now, each child would need to be tested prior to receiving the shot

Can Opioid Legislation Make a Dent in the National Epidemic?
Dozens of bills have been considered by the House

CRISPR-Edited Cells Linked to Cancer Risk in 2 Studies
The preliminary findings raise questions about one of the ways this tech edits genomes